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Abstract
Background: Memory retrieval is not a passive process. Recent studies have shown that reactivated memory is
destabilized and then restabilized through gene expression-dependent reconsolidation. Molecular studies on the
regulation of memory stability after retrieval have focused almost exclusively on fear memory, especially on the
restabilization process of the reactivated fear memory. We previously showed that, similarly with fear memories,
reactivated spatial memory undergoes reconsolidation in the Morris water maze. However, the underlying
molecular mechanisms by which reactivated spatial memory is destabilized and restabilized remain poorly
understood. In this study, we investigated the molecular mechanism that regulates the stability of the reactivated
spatial memory.
Results: We first showed that pharmacological inactivation of the N-methyl-D-aspartate glutamate receptor
(NMDAR) in the hippocampus or genetic inhibition of cAMP-responsible element binding protein (CREB)-mediated
transcription disrupted reactivated spatial memory. Finally, we showed that pharmacological inhibition of
cannabinoid receptor 1 (CB1) and L-type voltage gated calcium channels (LVGCCs) in the hippocampus blocked
the disruption of the reactivated spatial memory by the inhibition of protein synthesis.
Conclusions: Our findings indicated that the reactivated spatial memory is destabilized through the activation of
CB1 and LVGCCs and then restabilized through the activation of NMDAR- and CREB-mediated transcription. We
also suggest that the reactivated spatial memory undergoes destabilization and restabilization in the hippocampus,
through similar molecular processes as those for reactivated contextual fear memories, which require CB1 and
LVGCCs for destabilization and NMDAR and CREB for restabilization.
Background
To generate long-term memory (LTM), short-term
memory is stabilized through a new gene expression-
dependent process known as memory consolidation
[1-4]. Although it was previously thought that this con-
solidation occurs once, there is growing evidence indi-
cating that memory stability is changed to either
reinforce or alter memory after retrieval [5-11]. In fear
conditioning tasks, blocking protein synthesis before or
immediately after re-exposure to the conditioning sti-
mulus alone disrupts the subsequent expression of the
fear memory [10,12-14]. Such findings suggest that the
reactivated fear memory is destabilized and then restabi-
lized through a new gene expression-dependent process,
reconsolidation [10,12,13,15].
Abundant studies have focused on and investigated
the mechanisms underlying the restabilization of the
reactivated fear memory [13,15-21]. For example, we
previously demonstrated that the activation of
N-methyl-D-aspartate glutamate receptor (NMDAR)- and
cAMP-responsible element binding protein (CREB)-
mediated transcription is required for the reconsolida-
tion of contextual fear memory [13,14,22]. In contrast,
the mechanisms underlying the destabilization after
memory reactivation remain poorly understood. Only a
few studies, including ours, have shown that the desta-
bilization of reactivated fear memory depends on the
activation of NMDAR, proteasome-dependent protein
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voltage gated calcium channels (LVGCCs) [23-25].
Indeed, we showed that blockade of the function of
CB1 and LVGCCs protects reactivated contextual fear
memory from the amnesic effect of blocking protein
synthesis [25].
The formation of spatial memory in the Morris water
maze depends on the function of the hippocampus in
rodents [26]. Abundant studies using molecular genetics
and pharmacology have identified key molecules that
play essential roles in spatial learning and initial mem-
ory formation in the hippocampus [27-31]. On the other
h a n d ,w ep r e v i o u s l ys h o w e dt h a tt h er e a c t i v a t e ds p a t i a l
memory requires protein synthesis-dependent reconsoli-
dation for re-storage in the Morris water maze task [14].
Furthermore, other studies have demonstrated that the
reconsolidation of spatial memory depends on hippo-
campal protein and mRNA synthesis [32-35]. However,
the molecular mechanisms underlying the destabiliza-
tion/restabilization of reactivated spatial memory have
not been well characterized.
In this study we investigated the mechanisms for the
destabilization and restabilization of reactivated spatial
memory using the Morris water maze test. We first
showed the mechanism by which reactivated spatial
memory is restabilized, where reconsolidation of the
reactivated spatial memory is required for the activation
of NMDAR in the hippocampus and CREB-mediated
transcription. We next showed the mechanisms by
which the reactivated spatial memory is destabilized,
where destabilization of the reactivated spatial memory
is required for the activation of CB1 and LVGCCs in
the hippocampus. From these results, we concluded that
reactivated spatial and contextual fear memories
undergo a similar destabilization/reconsolidation (resta-
bilization) process in the hippocampus.
Results
Formation of spatial memory depends on protein
synthesis and NMDAR
We previously demonstrated that the reconsolidation of
spatial memory requires the synthesis of new proteins
[14]. In this previous study, mice were trained to find a
hidden platform with 6 trials per day over 2 days [14].
We first tried to confirm that mice can form a spatial
memory in this training condition, and tested whether
this memory formation requires protein synthesis and
the function of NMDAR in the hippocampus as pre-
viously shown [31,33,34,36,37].
Mice were trained on days 1 and 2 as described above
and received micro-infusions of the protein synthesis
inhibitor anisomycin (ANI) or the vehicle (VEH) into
the dorsal hippocampus immediately after the daily
training session (Figure 1A). Twenty-four hours after
training (day 3), mice were given a probe trial in which
the platform was removed from the pool. ANI-infused
mice showed worse memory performance during train-
ing at day 2, but not at day 1, compared to control mice
treated with VEH. A repeated-ANOVA comparing
escape latencies revealed a significant effect of drug
(VEH vs. ANI) at day 2, but not at day 1, although there
was no significant effect of drug versus session (day 1,
drug, F1,13 = 0.338, P > 0.05; session, F2,26 = 19.994, P <
0.05; drug vs. session, F2,26 = 0.325, P > 0.05; day 2,
drug, F1,13 = 32.794, P < 0.05; session, F2,26 =1 . 6 2 9 ,P>
0.05; group vs. session, F2,26 = 1.185, P > 0.05). Consis-
tently, the post hoc Bonferroni’st e s ts h o w e dt h a t
ANI-infused mice displayed significantly longer escape
latencies at day 2 than VEH-infused mice (P < 0.05)
(Figure 1B). These results indicated that the inhibition
of protein synthesis in the hippocampus following train-
ing at day 1 impaired the spatial memory. In the probe
test at day 3, VEH-infused, but not ANI-infused, mice
searched selectively in the target quadrant (TQ) of the
pool where the platform was previously located (Figure
1C). A one-way ANOVA revealed a significant effect of
group [TQ, opposite (OP), adjacent right (AR), and adja-
cent left (AL) quadrants] (VEH, F3,24 = 16.293, P < 0.05;
ANI, F3,28 = 2.822, P > 0.05). The post hoc Newman-
Keuls test showed that the ANI-infused group showed
no preference for the target location (P > 0.05), whereas
VEH-infused mice displayed significantly longer search-
ing scores in the TQ (time spent in the TQ) than in the
other quadrants (P < 0.05). Consistently, ANI-infused
mice showed significantly lower searching scores in the
TQ than VEH-infused mice (P < 0.05). These results
confirmed that ANI-infused mice failed to form a spatial
memory. Collectively, our observations confirmed the
previous findings that protein synthesis in the hippo-
campus is required for the formation of spatial memory
[33,34].
It is important to note that in our experimental condi-
tions, the infusion of ANI into the dorsal hippocampus
inhibited the induction of the immediate early gene
c-fos by a systemic administration of the chemical con-
vulsant pentylenetetrazol (PTZ) (Additional file 1, Figure
S1), confirming previous observations [25,38].
We next examined the effect of micro-infusions of an
NMDAR antagonist on the formation of spatial memory
(Figure 1). Mice were trained as described above and
received micro-infusions of the NMDAR antagonist AP5
(4 μg/μL) into the dorsal hippocampus immediately
after the daily training session (Figure 1A). In contrast
to the results for the micro-infusion of ANI, AP5-
infused mice showed comparable memory performance
during training at days 1 and 2 with VEH-infused mice
[day 1, drug (VEH vs. AP5), F1,14 = 0.427, P > 0.05; ses-
sion, F2,28 = 23.147, P < 0.05; drug vs. session, F2,28 =
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F2,28 = 4.416, P < 0.05; drug vs. session, F2,28 =0 . 5 8 7 ,
P > 0.05] (Figure 1B). Consistently, AP5- and VEH-
infused mice searched selectively in the TQ in the probe
test at day 3 (Figure 1C; VEH, F3,32 = 6.870, P < 0.05;
AP5, F2,21 = 4.552, P < 0.05) and showed comparable
searching scores in the TQ (P > 0.05). These observa-
tions indicated that the post-training infusion of AP5
into the hippocampus did not affect the formation of
spatial memory in our experimental design.
Previous studies suggested that spatial learning and
memory depend on the function of hippocampal
NMDAR [31]. Therefore, we further examined the effects
of a pre-training infusion of drugs (VEH, ANI, or AP5)
into the dorsal hippocampus. We performed a similar
experiment as in Figure 1A-C, except that mice received
micro-infusions of drugs into the dorsal hippocampus at
3 0m i nb e f o r et h ed a i l yt r a i n i n gs e s s i o n( F i g u r e1 D ) .
Similarly with the results shown in Figure 1B, the micro-
infusion of ANI impaired memory performance during
Figure 1 Roles of protein synthesis and NMDAR in the hippocampus in spatial learning and memory. (A) Experimental design. (B) Escape
latencies during training [VEH, n = 7; ANI, n = 8; AP5 (4 μg/μL), n = 9]. *P < 0.05 compared to the VEH-infused group at each block. Data are
indicated in blocks of 2 trials. (C) Probe trial at day 3. *P < 0.05, comparisons of searching scores in the TQ vs. time spent in the other quadrants
by post hoc Newman-Keuls test after significant one-way ANOVA.
#P < 0.05, comparisons of searching scores in the TQ with ANI-infused group.
(D) Experimental design. (E) Escape latencies during training [VEH, n = 11; ANI, n = 10; AP5 (1 μg/μL), n = 11; AP5 (2 μg/μL), n = 10; AP5 (4 μg/
μL), n = 11] *,
&, #, $ P < 0.05, ANI-, AP5 (1 μg/μL)-, AP5 (2 μg/μL)-, and AP5 (4 μg/μL)-infused groups, respectively, were compared to the VEH-
infused group at each block. (F) Probe trial at day 3. *P < 0.05, comparisons of searching scores in the TQ vs. time spent in the other quadrants
by post hoc Newman-Keuls test after significant one-way ANOVA.
&, #, $P < 0.05, comparisons of searching scores in the TQ with ANI-, AP5 (2 μg/
μL)- and AP5 (4 μg/μL)-infused groups, respectively. Error bars are SEM. Time spent (s) in target (T), adjacent left (L), adjacent right (R), and
opposite (O) quadrants during the probe trial is shown.
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Page 3 of 13training at day 2, but not at day 1 (day 1, drug, F1,19 =
0.563, P > 0.05; session, F2,38 = 16.724, P < 0.05; drug vs.
session, F2,38 =0 . 2 1 7 ,P>0 . 0 5 ;d a y2 ,d r u g ,F 1,19 =
50.247, P < 0.05; session, F2,38 = 5.273, P < 0.05; drug vs.
session, F2,38 = 0.628, P > 0.05) (Figure 1E). Consistently,
in the probe test at day 3, ANI-infused mice showed no
preference for the TQ (F3,36 = 1.697, P > 0.05), whereas
VEH-infused mice searched selectively in the TQ com-
pared to the other quadrants (F3,40 = 33.255, P < 0.05)
(Figure 1F). ANI-infused mice showed significantly lower
searching scores in the TQ than VEH-infused mice (P <
0.05). These observations indicated that pre-treatment
with ANI at 30 min before training was sufficient to
block the formation of spatial memory.
Interestingly, the pre-training infusion of AP5 into the
dorsal hippocampus impaired memory performance dur-
ing training at both days 1 and 2 (Figure 1E). A repeated
ANOVA across drugs [VEH, and low-, middle-, and
high-doses of AP5 (1, 2 and 4 μg/μL)] revealed signifi-
cant effects of drugs and a drugs versus session interac-
tion at day 1 (drug, F3,39 = 14.778, P < 0.05; session,
F2,78 = 9.516, P < 0.05; drug vs. session, F2,78 =2 . 6 0 9 ,
P < 0.05) and a significant effect of drugs at day 2 (drug,
F3,39 = 25.387, P < 0.05; session, F2,78 = 10.041, P > 0.05;
drug vs. session, F2,78 = 1.750, P > 0.05). Consistently,
the middle- and high-, but not low-, dose AP5-infused
mice showed significantly longer escape latencies during
training at days 1 and 2 than VEH-infused mice (P <
0.05) (Figure 1E). In the probe test at day 3, low-, but
not middle- or high-, dose AP5-infused mice searched
selectively in the TQ compared to the other quadrants
(low, F3,40 = 27.181, P < 0.05; middle, F3,36 = 2.226, P >
0.05). Although one-way ANOVA detected a significant
effect of group in the high-dose AP5-infused mice (F3,40 =
7.517, P < 0.05), these mice failed to display significantly
higher searching scores in the TQ compared to the
other quadrants. Consistently, one-way ANOVA com-
paring the time spent in the TQ revealed a significant
effect of group (F3,39 = 13.344, P < 0.05). High-dose
AP5-infused mice showed significantly lower searching
scores in the TQ compared to all of the other groups
(P < 0.05), whereas middle-dose AP5-infused mice
showed significantly lower scores than the VEH- and
low-dose AP5-infused mice (P > 0.05). These observa-
tions indicated that the infusion of AP5 into the dorsal
hippocampus impaired spatial learning and memory in
a dose-dependent manner.
It is possible that blocking the formation of spatial
memory by ANI and AP5 was due to the disruption of
the hippocampus function, and not target inhibition of
signal transduction such as protein synthesis- and
NMDAR-mediated signals. To examine these possibili-
ties, we performed a contextual fear conditioning task,
known as the hippocampus-dependent task [39], using
mice assessed spatial memory as shown in Figure 1D-F
(Additional file 2, Figure S2). Mice were trained with a
single footshock (0.4 mA) in the context chamber (train-
ing) and freezing was assessed in the same context for
5 min at 24 h after training (test). Twenty-four hours
following training, ANI- and AP5-infused mice showed
comparable levels of freezing compared to VEH-infused
mice (F4,42 = 0.683, P > 0.05), suggesting that ANI- and
AP5-infused mice formed normal contextual fear mem-
ories. These observations suggest that treatment with
neither ANI nor AP5 led to significant damage of hip-
pocampal function.
Collectively, these results confirmed previous findings
and indicated that spatial learning and memory depends
on NMDAR and protein synthesis. It is also suggested
that NMDAR and protein synthesis display distinct time
windows for spatial learning and memory; NMDAR is
required at an earlier stage compared to protein
synthesis.
Reconsolidation of spatial memory depends on protein
synthesis and NMDAR
We previously demonstrated that reactivated spatial
memory requires protein synthesis-dependent reconsoli-
dation for re-storage [14]. Furthermore, other studies
extended this finding and indicated that the reconsolida-
tion of spatial memory depends on protein synthesis in
the hippocampus [[33,35], but also see [34]]. To further
clarify the mechanisms for the reconsolidation of reacti-
vated spatial memory, we first examined the roles of
hippocampal protein synthesis and NMDAR in the
reconsolidation of spatial memory (Figure 2).
Mice were trained over 2 days (days 1 and 2) as
described above (Figure 1). Twenty-four hours after
training (day 3), the first probe trial was performed to
reactivate the spatial memory [probe test 1 (PT 1), Re-
exposure]. Immediately after PT 1, mice received a
micro-infusion of drugs (VEH, ANI, or AP5) into the
dorsal hippocampus. Twenty-four hours after PT 1
(day 4), the second probe trial (PT 2, Test) was per-
formed to assess spatial memory. In these experimental
protocols, we previously observed that a systemic injec-
tion of ANI disrupted reactivated spatial memory [14].
Similarly with the results presented in Figure 1, all
groups of mice showed comparable memory perfor-
mance and a progressive loss of escape latencies during
training (days 1 and 2) (data not shown). Twenty-four
hours after training on day 2, all groups of mice selec-
tively searched the TQ in PT 1 (VEH, F3,32 = 26.244,
P < 0.05; ANI, F3,40 = 29.418, P < 0.05; AP5 1 μg/μL,
F3,36 = 55.537, P < 0.05; AP5 2 μg/μL, F3,44 = 60.396,
P < 0.05; AP5 4 μg/μL, F3,52 = 36.892, P < 0.05). Consis-
tently, comparisons of the time spent in the TQ showed
that all groups displayed comparable searching scores in
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that all groups formed and reactivated spatial memory.
Twenty-four hours after PT 1, VEH-infused, but not
ANI-infused, mice selectively searched the TQ in PT 2
(VEH, F3,32 = 13.314, P < 0.05; ANI, F3,40 = 1.524, P >
0.05) (Figure 2C). ANI-infused mice showed a signifi-
cant decrease in searching scores in the TQ in PT 2
than in PT 1 (F1,20 = 18.454, P < 0.05) and significantly
lower searching scores than VEH-infused mice in PT 2
(F1,18 = 10.435, P < 0.05). These observations indicated
that inhibition of protein synthesis in the hippocampus
disrupted spatial memory after reactivation, confirming
the previous finding that hippocampal protein synthesis
is required for the reconsolidation of spatial memory
[33,35].
Similarly with the results of ANI, the blockade of
NMDAR in the hippocampus also impaired the reacti-
vated spatial memory (Figure 2C). The low-(1 μg/μL)
and middle-(2 μg/μL), but not high-(4 μg/μL), dose
AP5-infused mice selectively searched the TQ in PT 2
(low, F3,36 = 16.937, P < 0.05; middle: F3,44 = 5.665, P <
0.05; high, F3,52 = 1.970, P > 0.05). Consistently, high-
dose AP5-infused mice showed a significant decrease in
searching scores in the TQ compared to PT 1 (P <
0.05). Additionally, a one-way ANOVA comparing
searching scores in the TQ in PT 2 among VEH- and
AP5-infused mice revealed a significant effect of group
(F3,41 = 3.984, P < 0.05). High-dose AP5-infused mice
showed significantly lower searching scores in the TQ
than VEH- and low-dose AP5-infused mice (P < 0.05).
The middle-dose AP5-infused group showed slightly
lower and higher searching scores in the TQ than the
low- or high-dose AP5-infused groups, respectively,
although these differences were not statistically signifi-
cant. These observations indicated that the inhibition of
NMDAR in the hippocampus impaired reactivated spa-
tial memory in a dose-dependent manner, suggesting
that the activation of hippocampal NMDAR is required
for the reconsolidation of spatial memory (Figure 2C).
Similarly with Figure 1, we performed a contextual
fear conditioning test using mice assessed the reconsoli-
dation of spatial memory as shown in Figure 2 (Addi-
tional file 2, Figure S2) and observed that all groups of
mice formed normal contextual fear memory (F4,51 =
0.423, P > 0.05). These observations suggest that treat-
ment with neither ANI nor AP5 led to significant
damage of the function of the hippocampus.
As a control experiment, we examined whether the
disruption of spatial memory by protein synthesis inhibi-
tion depends on memory reactivation at Re-exposure
(PT 1). We performed a similar experiment as in
Figure 2, except that mice were not given PT 1 (No Re-
exposure). However, mice were micro-infused with ANI
or VEH into the dorsal hippocampus at 24 h after train-
ing on day 2. Both groups of mice showed comparable
memory performance and a progressive loss of escape
latencies during training (days 1 and 2) (data not
shown). In contrast to the results shown in Figure 2,
Figure 2 Roles of protein synthesis and NMDAR in the hippocampus in the reconsolidation of spatial memory. (A) Experimental design.
(B) Probe trial at day 3 (PT 1) [VEH, n = 9; ANI, n = 11; AP5 (1 μg/μL), n = 10; AP5 (2 μg/μL), n = 12; AP5 (4 μg/μL), n = 13]. *P < 0.05,
comparisons of searching scores in the TQ vs. time spent in the other quadrants by post hoc Newman-Keuls test after significant one-way
ANOVA. (C) Probe trial at day 4 (PT 2). *P < 0.05, time spent in the TQ vs. time spent in the other quadrants by post hoc Newman-Keuls test after
significant one-way ANOVA.
$, #P < 0.05, comparisons of searching scores in the TQ with ANI- and AP5 (4 μg/μL)-infused groups, respectively.
Error bars are SEM. Time spent (s) in target (T), adjacent left (L), adjacent right (R), and opposite (O) quadrants during the probe trial is shown.
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TQ in the probe test (VEH, F3,32 = 16.485, P < 0.05;
ANI, F3,32 = 10.108, P < 0.05) (Figure 3). ANI-infused
mice showed comparable searching scores in the TQ as
the VEH group (F1,16 = 0.002, P > 0.05). These results
indicated that the inhibition of protein synthesis failed
to disrupt spatial memory when the memory was not
reactivated by the Re-exposure session, suggesting that
the amnesic effects of ANI are contingent on the reacti-
vation of spatial memory.
Reconsolidation of spatial memory depends on CREB-
mediated transcription
We previously demonstrated that CREB-mediated tran-
scription is required for the reconsolidation of contextual
fear memory [13,22,25]. To further understand the
mechanism for the reconsolidation of spatial memory, we
examined the role of CREB-mediated transcription in the
reconsolidation of spatial memory using CREB
IR mice
[13,22,25] (Figure 4).
We performed a similar experiment as shown in
Figure 2, except that CREB
IR mice and wild type (WT)
littermates received a systemic injection of tamoxifen
(TAM; 16 mg/kg, i.p.) or peanut oil (VEH) at 6 h before
PT 1 to induce the inhibition of CREB activity (Figure
4A). Similarly with Figure 2, all groups of mice showed
comparable memory performance and a progressive loss
of escape latencies during training (days 1 and 2) (data
not shown). Twenty-four hours after training on day 2,
all groups searched selectively and comparably in the
Figure 3 Effect of no re-exposure on the stability of spatial memory. (A) Experimental design. (B) Probe trial at day 4 (VEH, n = 9; ANI, n =
9). *P < 0.05, time spent in the TQ vs. time spent in the other quadrants by post hoc Newman-Keuls test after significant one-way ANOVA. Error
bars are SEM. Time spent (s) in target (T), adjacent left (L), adjacent right (R), and opposite (O) quadrants during the probe trial is shown.
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WT/TAM, F3,32 = 29.077, P < 0.05; CREB
IR/VEH, F3,24 =
13.937, P < 0.05; CREB
IR/TAM, F3,36 = 22.310, P <
0.05) (Figure 4B). Importantly, our observation that
TAM-injected CREB
IR mice displayed normal searching
scores in the TQ suggests that the genetic inhibition of
CREB activity had no effect on the retrieval of spatial
memory.
In contrast to these observations, TAM-injected CRE-
B
IR mice showed no preference for the TQ in PT 2,
while the other groups selectively searched in the TQ
(WT/VEH, F3,44 = 9.187, P < 0.05; WT/TAM, F3,32 =
13.971, P < 0.05; CREB
IR/VEH, F3,24 = 13.516, P < 0.05;
CREB
IR/TAM, F3,35 = 1.941, P > 0.05) (Figure 4C).
TAM-injected CREB
IR mice showed a significant
decrease in their searching scores in the TQ compared
to PT 1 (F1,18 = 10.230, P < 0.05). Consistently, two-way
ANOVA comparing searching scores in the TQ in PT 2
revealed a significant drug versus genotype interaction
(drug, F1,33 = 2.438, P > 0.05; genotype, F1,33 =1 . 9 3 1 ,P>
0.05; drug vs. genotype, F1,33 = 9.389, P < 0.05). TAM-
injected CREB
IR mice showed significantly lower search-
ing scores in the TQ compared to the other groups
(P < 0.05). These observations indicated that the inhibi-
tion of CREB-mediated transcription disrupted reacti-
vated spatial memory, suggesting that CREB-mediated
transcription is required for the reconsolidation of spatial
memory.
Destabilization of reactivated spatial memory depends on
the activation of CB1 and LVGCCs
We previously demonstrated that the activation of CB1
and LVGCCs in the hippocampus is required for the
destabilization of reactivated contextual fear memory
[25]. To understand the mechanisms for the destabiliza-
tion of reactivated spatial memory, we examined
whether the blockade of hippocampal CB1 or LVGCCs
would block the amnesic effect of ANI on reactivated
spatial memory (Figure 5).
We performed a similar experiment as in Figure 2,
except that mice received a micro-infusion of ANI or
VEH with either the CB1 blocker SR141716A (SR) or the
LVGCC blocker verapamil-HCl (VER) into the dorsal
hippocampus immediately after PT 1. All groups of mice
showed comparable memory performance and a progres-
sive loss of escape latencies during training (days 1 and 2)
Figure 4 Role of CREB-mediated transcription in the reconsolidation of spatial memory. (A) Experimental design. (B) Probe trial at day 3
(PT 1) (WT/VEH, n = 12; WT/TAM, n = 9; CREB
IR/VEH, n = 9; CREB
IR/TAM, n = 10). *P < 0.05, time spent in the TQ vs. time spent in the other
quadrants by post hoc Newman-Keuls test after significant one-way ANOVA. (C) Probe trial at day 4 (PT 2). *P < 0.05, time spent in the TQ vs.
time spent in the other quadrants by post hoc Newman-Keuls test after significant one-way ANOVA.
#P < 0.05, comparisons of searching scores
in the TQ among the experimental groups of mice. Error bars are SEM. Time spent (s) in target (T), adjacent left (L), adjacent right (R), and
opposite (O) quadrants during the probe trial is shown.
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day 2, all groups of mice searched selectively and com-
parably in the TQ during PT 1 (VEH, F3,56 = 46.208, P <
0.05; ANI, F3,56 = 45.649, P < 0.05; SR, F3,52 = 60.259, P <
0.05; VER, F3,48 = 35.274, P < 0.05; SR 2 μg/μL+A N I ,
F3,28 = 32.731, P < 0.05; SR 4 μg/μL+A N I ,F 3,36 =
26.661, P < 0.05; SR 8 μg/μL+A N I ,F 3,52 = 51.078, P <
0.05; VER 1 μg/μL+A N I ,F 3,28 = 28.652, P < 0.05; VER
2 μg/μL+A N I ,F 3,32 = 21.713, P < 0.05; VER 4 μg/μL+
ANI, F3.56 = 69.306, P < 0.05) (Figure 5B).
Consistent with the results shown in Figure 2, we
observed that the inhibition of protein synthesis dis-
rupted the reactivated spatial memory. However, this dis-
ruption by ANI was reversed by the co-infusion of either
SR or VER in a dose-dependent manner, while the block-
ade of CB1 or LVGCCs in the absence of ANI left the
spatial memory unaffected (Figure 5C). ANI-, but not
VEH-, infused mice failed to selectively search in the TQ
during PT 2 (VEH, F3,56 = 21.850, P < 0.05; ANI, F3,56 =
2.311, P > 0.05). In contrast, mice co-infused with ANI
and higher doses of SR (4 or 8 μg/μL) or VER (2 or 4 μg/
μL) selectively searched in the TQ (SR, 4 μg/μL, F3,36 =
3.992, P < 0.05; 8 μg/μL, F3,52 = 25.462, P < 0.05; VER,
2 μg/μL, F3,32 = 3.517, P < 0.05; 4 μg/μL, F3,56 = 37.015,
P < 0.05). Although one-way ANOVA also detected a sig-
nificant effect of group in the mice co-infused with ANI
and low-doses of SR (2 μg/μL) or VER (1 μg/μL) (SR,
F3,28 = 3.003, P < 0.05; VER, F3,28 = 8.882, P < 0.05), these
mice failed to display significantly higher searching scores
in the TQ compared to the other quadrants. Additionally,
SR- or VER-infused mice (without the infusion of ANI)
selectively searched in the TQ (SR, F3,52 = 31.122, P <
0.05; VER, F3,48 = 52.560, P < 0.05).
Two-way ANOVA with drug 1 (VEH vs. ANI) and
drug 2 [VEH vs. SR (8 μg/μL) or VER (4 μg/μL)] com-
paring searching scores in the TQ confirmed the obser-
vations described above. We observed significant effects
of drug 1 and drug 2, but no significant drug 1 versus
drug 2 interaction (SR, drug 1, F1,54 = 14.090, P < 0.05;
drug 2, F1,54 = 8.605, P < 0.05; drug 1 vs. drug 2, F1,54 =
2.728, P > 0.05; VER, drug 1, F1,38 = 15.151, P < 0.05;
drug 2, F1,38 = 0.091, P > 0.05; drug 1 vs. drug 2: F1,38 =
0.001, P > 0.05). These results reflected the fact that SR-
or VER-infused mice showed significantly higher search-
ing scores in the TQ regardless of whether they were
co-infused with ANI. The post hoc Bonferroni’st e s t
showed that ANI-infused mice [without the infusion of
SR (8 μg/μL) or VER (4 μg/μL)] displayed a significantly
lower searching score in the TQ compared to the other
groups (P < 0.05) that displayed comparable searching
scores in the TQ (Ps > 0.05). These results indicated
that the co-infusion of SR or VER with ANI into the
dorsal hippocampus prevented the disruption of reacti-
vated memory by the inhibition of protein synthesis.
Figure 5 Roles of CB1 and LVGCCs in the hippocampus in the destabilization of spatial memory. (A) Experimental design. (B) Probe trial
at day 3 (PT 1) (n = 8-15 for all groups). *P < 0.05, time spent in the TQ vs. time spent in the other quadrants by post hoc Newman-Keuls test
after significant one-way ANOVA. (C) Probe trial at day 4 (PT 2). *P < 0.05, time spent in the TQ vs. time spent in the other quadrants by post
hoc Newman-Keuls test after significant one-way ANOVA.
#P < 0.05, comparisons of searching scores in the TQ among the experimental groups
of mice. Error bars are SEM. Time spent (s) in target (T), adjacent left (L), adjacent right (R), and opposite (O) quadrants during the probe trial is
shown.
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the TQ among mice co-infused with ANI and with or
without low-, middle-, and high-doses of SR (2, 4, and
8 μg/μL) or VER (1, 2, and 4 μg/μL) revealed a signifi-
cant effect of group (SR, F3,43 = 4.235, P < 0.05; VER,
F3,43 = 5.743, P < 0.05). Mice co-infused with ANI and
with middle- or high-doses of SR or VER showed signif-
icantly higher searching scores in the TQ than the other
groups (P < 0.05). Additionally, mice co-infused with
ANI and with low-dose SR or VER showed higher
searching scores in the TQ than mice infused only with
ANI, although these differences were not statistically
significant. These results indicated that SR and VER dis-
played inhibitory effects on the disruption of reactivated
spatial memory by the inhibition of protein synthesis in
a dose-dependent manner.
It is important to note that, consistent with previous
observations [25], the co-infusion of SR or VER with
ANI showed no inhibitory effect on the induction of
PTZ-induced c-fos expression by ANI (Additional file 3,
Figure S3).
Collectively, these observations indicated that the hip-
pocampal activation of CB1 and LVGCCs is required for
the destabilization of reactivated spatial memory.
Discussion
Previous studies have shown that retrieval temporarily
destabilizes memory, and that gene expression-
dependent processes are required for subsequent resta-
bilization (memory reconsolidation) [10,12,13,15].
Molecular studies on the regulation of memory stability
after retrieval have focused almost exclusively on fear
memory, while the underlying molecular mechanisms
for the reconsolidation of spatial memory remain poorly
understood, except for a few studies showing that the
reconsolidation of spatial memory requires mRNA and
protein synthesis and the function of protein kinase C
(PKC) [14,32-35,40]. In this current study, we first
showed that the reactivated spatial memory undergoes
reconsolidation, which is dependent on protein synthesis
in the hippocampus, confirming previous findings
[[33,35], but also [34]]. Using this experimental condi-
tion, we investigated the molecular mechanisms by
which the reactivated spatial memory is destabilized and
restabilized (reconsolidated). We observed that the
destabilization of the reactivated spatial memory
requires the hippocampal activation of CB1 and
LVGCCs, whereas restabilization of the spatial memory
requires the hippocampal activation of NMDAR and
CREB-mediated transcription.
Previous studies have shown that the activation of
NMDAR is required for spatial learning [31,37,41].
Indeed, genetic studies indicated that genetic deletion of
the NMDAR-subunits NR1 or NR2A impaired spatial
learning [37,41], whereas the forebrain-specific overex-
pression of NR2B led to the enhancement of spatial
learning [42,43]. Consistently, we showed that pharma-
cological inhibition of NMDAR by AP5 in the dorsal
hippocampus impaired spatial learning. Furthermore, we
found that this inhibition also blocked the reconsolida-
tion of reactivated spatial memory. Our observations
confirmed and extended the previous finding that
NMDAR activation is required for spatial learning, and
indicated that NMDAR activation is also required for
the reconsolidation of spatial memory.
We observed that the post-training, but not pre-train-
ing, infusion of AP5 into the dorsal hippocampus failed
to impair spatial learning and memory. Previous studies
using contextual fear conditioning reported similar
observations [44]; a pre-training intra-hippocampal infu-
sion of AP5 impaired memory, while a post-training
infusion did not. In contrast to these observations, both
pre- and post-infusions of ANI into the dorsal hippo-
campus blocked the formation of spatial memory. More-
over, mice that received this pre-infusion of ANI
showed normal spatial learning during training at day 1,
although they displayed impaired spatial memory at the
first training session on day 2, indicating that the inhibi-
tion of protein synthesis, blocked the formation of spa-
tial memory without affecting spatial learning. Taken
together, these observations suggest that the activation
of NMDAR and protein synthesis in the hippocampus
play distinct roles in spatial learning and memory; the
activation of NMDAR is required during the early stages
of spatial learning and memory compared to the activa-
tion of gene expression that is required in the consolida-
tion phases of memory. However, we could not exclude
the possibility that the activation of NMDAR is also
required during the initial stage of spatial memory con-
solidation, as previously reported [45], because the infu-
sion of AP5 after training, which consisted of 6 trials
and took longer than 20 min to complete, may be too
late to block NMDAR function at the critical time point
when NMDAR is required after learning. In addition, in
contrast to our observations, previous studies have
shown that pharmacological inhibition or hippocampal
CA3 region-specific genetic deletion of NMDAR did not
affect spatial leaning [46,47]. As discussed above, it is
possible that there may be a narrow time window and/
or a brain-region specificity when or where, respectively,
NMDAR is required for spatial learning [37]. On the
other hand, there is a possibility that the pharmacologi-
cal treatment of ANI or AP5 at day 2 affected reconsoli-
dation of spatial memory that was formed at day 1.
However, it is difficult to further examine whether
impairments in spatial memory observed in the probe
trial at day 3 is due to the inhibition of consolidation or
reconsolidation of spatial memory at day 2 because mice
Kim et al. Molecular Brain 2011, 4:9
http://www.molecularbrain.com/content/4/1/9
Page 9 of 13could not form a spatial memory at day 1 (6 trials) and
required more trainings at day 2 (additional 6 trials) to
form a spatial memory in our training protocol (data
not shown). Further studies are required to investigate
whether contributions of consolidation and reconsolida-
tion to strengthening spatial memory during daily train-
ing trials are dissociable.
We previously demonstrated that the reconsolidation
of a reactivated contextual fear memory requires the
activation of NMDAR [14] and CREB-mediated tran-
scription [13,22,25]. We extended these findings and
indicated that the activation of hippocampal NMDAR
and CREB-mediated transcription is required for the
reconsolidation of reactivated spatial memory. Indeed,
pharmacological blockade of hippocampal NMDAR and
genetic inhibition of CREB-mediated transcription dis-
rupted reactivated spatial memory. On the other hand,
we previously demonstrated that the destabilization of
reactivated contextual fear memory requires the hippo-
campal activation of CB1 and LVGCCs [25]. We also
extended these findings and indicated that the activation
of CB1 and LVGCCs is required for the destabilization
of reactivated spatial memory. Similarly with previous
observations, the blockade of CB1 or LVGCCs in the
hippocampus by SR or VER, respectively, blocked the
disruption of reactivated spatial memory by inhibiting
protein synthesis. Thus, reactivated contextual fear and
spatial memories undergo destabilization and restabiliza-
tion (reconsolidation) through similar molecular pro-
cesses in the hippocampus, raising the possibility that
common molecular pathways regulate the stability of
these memories in the hippocampus [13,14,20,22,25,33].
Previous study has shown that the pharmacological
blockade of NMDAR by pre-, but not post-, re-exposure
infusion of a NMDAR blocker into the amygdala
impaired the destabilization of reactivated cued fear
memory [24]. On the other hand, we observed that this
blockade by post-re-exposure infusion into the hippo-
campus disrupted the reactivated spatial memory,
indicating that the blockade of NMDAR in the hippo-
campus did not affect the destabilization of spatial
memory after retrieval. It is possible that the function of
NMDAR on destabilization and restabilization differs in
brain regions and types of memory. Moreover, there is
another possibility that the requirements of NMDAR for
destabilization and restabilization of reactivated memory
display distinct critical time windows although NMDAR
is required for both destabilization and restabilization of
reactivated memory.
How do CB1 and LVGCCs cooperatively regulate the
destabilization of reactivated memory? LVGCCs are
known to be post-synaptically expressed in the excitatory
neurons of the hippocampus and increase the post-
synaptic Ca
2+ concentration in response to depolarization.
In contrast, endocannabinoids are released in response to
the increase in post-synaptic Ca
2+ concentration and then
act as a retrograde signal to activate pre-synaptic CB1,
leading to decreased neurotransmitter release from the
pre-synaptic neuron. Therefore, it is possible that CB1 is
activated via the activation of post-synaptic LVGCCs.
Furthermore, a recent study has shown that protein degra-
dation via the proteasome is required for the destabiliza-
tion of reactivated contextual fear memory [23]. Further
studies are necessary to investigate the molecular cascades
linking CB1, LVGCCs, and proteasome activity to destabi-
lize reactivated memory.
Methods
Mice
All experiments were conducted according to the Guide
for the Care and Use of Laboratory Animals, Japan Neu-
roscience Society and the Guide for the Tokyo University
of Agriculture. Male C57BL/6 mice were obtained from
Charles River. Transgenic male mice expressing an
inducible CREB repressor (CREB
IR mice) have been
backcrossed to C57BL/6 [13,22,25]. Five or 6 mice were
housed in cages, maintained on a 12 h light/dark cycle,
and allowed ad libitum access to food and water. Mice
were at least 8 weeks of age when tested. Testing was
performed during the light phase of the cycle. All
experiments were conducted blind to the treatment con-
dition of the mouse.
Surgery
Surgeries were performed as described previously
[22,25,38]. Under Nembutal anesthesia and using
standard stereotaxic procedures, stainless-steel guide
cannulae (22-gauge) were implanted into the dorsal hip-
pocampus (-1.8 mm, ± 1.8 mm, -1.9 mm). Mice were
allowed to recover for at least 1 week following surgery.
Following this, they were handled for 5 consecutive days
prior to the commencement of the Morris water maze.
Drugs
The protein synthesis inhibitor anisomycin (ANI;
125 μg/μL; Sigma), CB1 antagonist SR141716A (2, 4, or
8 μg/μL) [14,25,48], and LVGCCs antagonist verapamil-
HCl (VER; 1, 2, or 4 μg/μL; Sigma) [25] were dissolved
in vehicle solution, containing 3 drops of Tween 80 in
2.5 mL of 7.5% dimethyl sulphoxide in artificial cere-
brospinal fluid (ACSF) and adjusted to pH 7.4 with
NaOH. The NMDA receptor antagonist D-AP5 (1, 2, or
4 μg/μL; Sigma) was dissolved in ACSF. For experiments
using the CREB
IR mice, 4-hydroxytamoxifen (TAM;
16 mg/kg, i.p.; Sigma) was dissolved in 10 mL of peanut
oil (Sigma) [13,22,25].
Kim et al. Molecular Brain 2011, 4:9
http://www.molecularbrain.com/content/4/1/9
Page 10 of 13Morris water maze
The water maze apparatus and procedures have been
described previously [14,28]. Mice were trained with 6
trials per day for 2 days (at 1 min intervals) (training).
Spatial learning and memory were assessed in probe
trials with the platform removed from the pool. In
probe trials, mice were allowed to swim for 60 s and the
time spent in each quadrant of the pool was scored.
For the acquisition and formation of spatial memory
experiment (Figure 1), mice were infused with vehicle
(VEH) or drugs (ANI or AP5) into the dorsal hippocam-
pus at 30 min before or immediately after training.
Twenty-four hours following the training session on day
2, mice performed a probe trial. For the reconsolidation
experiment (Figure 2), mice were trained and given the
first probe trial (PT 1; Re-exposure) as described above.
Mice were infused with VEH or drugs (ANI and AP5)
into the dorsal hippocampus immediately after PT 1.
Twenty-four hours after PT 1, mice performed the sec-
ond probe trial (PT 2; Test). In the experiment using
CREB
IR mice (Figure 4), mice were trained and given
probe trials as in Figure 2. Mice received a systemic
injection of TAM or peanut oil at 6 h before PT 1. For
the destabilization experiment (Figure 5), mice were
trained and given probe trials as in Figure 2. Mice were
infused with VEH or drugs (ANI, SR, or VER) into the
dorsal hippocampus immediately after PT 1. Infusions
into the dorsal hippocampus (0.5 μL) were made at a
rate of 0.25 μL/min for 2 min. The injection cannulae
was left in place for 2 min following the infusion.
Cannulae tip placements are shown in the supplemen-
tary data, and only mice with cannulae tips within the
boundaries of the hippocampus were included in the
data analysis (Additional file 4, Figure S4).
Contextual fear conditioning test
Mice were trained and tested in conditioning chambers
(17.5 × 17.5 × 15 cm) that had a stainless-steel grid floor
through which footshock could be delivered [22,25].
Training consisted of placing the mice in the chamber
and delivering an unsignaled footshock (2 s duration,
0.4 mA) at 148 s later. Mice were returned to their home
cages at 30 s after footshock. Twenty-four hours later,
mice were placed back in the training context for 5 min
during which freezing behavior was assessed (test).
Immunocytochemistry
To indirectly examine the impact of CB1 and LVGCCs
blockers on protein synthesis inhibition by ANI, we
examined the induction of the activity-regulated gene
c-fos by the chemical convulsant pentylenetetrazol (PTZ;
50 mg/kg, i.p.). Mice were infused with SR or VER into 1
side of the hippocampus and co-infused with ANI and
SR or VER into the other side. Thirty minutes following
this, mice were treated with PTZ. Thirty minutes later,
all mice were perfused transcardially. Brains were subse-
quently prepared for immunocytochemistry using an
anti-c-fos primary rabbit polyclonal antibody (Ab-5,
1:5000; Calbiochem), as previously described [25,38].
Staining was revealed using the streptavidin-biotin perox-
idase method (SAB-PO Kit; Nichirei Biosciences, Inc.).
Quantification of c-fos-positive cells in sections (100 μm
× 100 μm) of the dentate gyrus (DG) was analyzed with
Winroof Ver. 5.6 software (Mitani Corp.). The advantage
of using PTZ in these experiments is that it induces high
levels of c-fos expression, thereby making it easier to
detect any reductions in c-fos expression by pretreatment
with ANI.
Data analysis
Data were analyzed with ANOVA. One-way and post
hoc Newman-Keuls comparisons were used to analyze
the differences of the time spent in each quadrant for
each group in the Morris water maze test, and the dif-
ferences in the freezing scores from the contextual fear
conditioning test. One- and two-way ANOVA followed
by post hoc Newman-Keuls and post hoc Bonferroni’s
comparisons, respectively, were used to analyze the
effects of drugs and genotype on the time spent in the
target quadrant (TQ) in the Morris water maze test.
A repeated ANOVA followed by post hoc Bonferroni’s
were used to analyze the effects of drugs on escape
latencies. Planned comparisons using Student’s t test
were used to analyze the differences of the number of c-
fos positive cells from immunocytochemistry. All values
in the text and figure legends are means ± SEM.
Additional material
Additional file 1: Figure S1. Effect of protein synthesis inhibition in
the hippocampus by ANI on the induction of c-fos by PTZ
treatment. (A) Images of hippocampal c-fos-positive cells in the
indicated mice. (B) Quantitative analyses of c-fos expression in the
dentate gyrus (VEH, n = 6; ANI, n = 6). Data for c-fos activation in each
group were expressed as the percentage of the averaged values in the
VEH group. Error bars are SEM. *P < 0.05 compared to the VEH-infused
group by Student’s t test.
Additional file 2: Figure S2. Results of the contextual fear
conditioning test. Error bars are SEM.
Additional file 3: Figure S3. Effects of blocking CB1 and LVGCCs in
the hippocampus on the inhibition of the PTZ-induced expression
of c-fos by ANI. (A) Images of hippocampal c-fos-positive cells in the
indicated mice. (B) Quantitative analyses of c-fos expression the in
dentate gyrus (n = 4 for all groups). Data for c-fos activation in each
group were expressed as the percentage of the averaged values in the
SR or VER-infused groups. Error bars are SEM. *P < 0.05 compared to the
SR or VER-infused group by Student’s t test.
Additional file 4: Figure S4. Illustrating cannulae tip placements in
the hippocampus. Coronal drawings showing the placement of the
cannulae tip in the experiments shown in Figure 1A-C, Figure 1D-F,
Figure 2, Figure 3, and Figure 5. Only mice with needle tips within the
boundaries of the hippocampus were included in the data analysis.
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